期刊文献+

钼靶微钙化对乳腺癌的诊断及预后价值 被引量:11

The clinical diagnostic value and prognosis of breast cancer with mammography micro-calcifications
下载PDF
导出
摘要 目的 通过研究乳腺钼靶显示微钙化的乳腺癌的临床生物学行为,为乳腺癌的诊断及预后评价寻找新的指标.方法 对315例原发性乳腺癌患者术前应用钼靶摄影机常规摄取乳腺轴位、斜位片,判断有无微钙化,并与肿瘤类型、大小、临床分期、组织学分级、腋下淋巴结转移情况及ER、PR、C-erbB-2等临床病理学指标进行分析,比较各临床指标与钼靶钙化的关系.结果 浸润性导管癌合并导管内癌组中微钙化阳性率显著高于单纯浸润性导管癌组(P〈0.05).微钙化与临床分期呈正相关[以I期为对照,II期OR=1.822(95% CI 1.013~3.276),III期OR=3.646(95% CI 1.772~7.503),P〈0.05],与淋巴结转移呈正相关[OR=1.761(95%CI 1.124~2.760),P〈0.05].微钙化与ER阳性表达呈正相关[OR=1.710(95%CI 1.078~2.712),P〈0.05],与PR阳性表达呈正相关[OR =1.597(95%CI 1.023~2.494),P〈0.05].结论 钼靶微钙化阳性患者更倾向于临床分期晚、腋窝淋巴结转移以及ER、PR阳性表达,能否作为判断预后的独立因素还有待进一步研究. Objective To investigate the biological behavior of breast cancer with mammography showed micro-calcifications,search for new indicators for preoperative evaluation of prognosis.Methods 315 cases of primary breast cancer patients were enrolled,took preoperative mammography film with regular intake of breast axis and oblique view,these patients were divided into calcification and no calcification group.Analyzed clinical and pathological indicators such as tumor type,size,clinical stage,histological grade,armpit lymph node metastasis and ER and PR,C-erbB-2 and compared the clinical indicators with mammography calcification.Results The rate of malignant calcification group in invasive ductal cancer with intra-ductal carcinoma group was significantly higher than invasive ductal carcinoma group(P 0.05).Calcification and clinical stage was positively correlated(take stage Ⅰ as control,stage Ⅱ;OR = 1.822,95%CI 1.013-3.276;stage Ⅲ;OR =3.646,95%CI 1.772-7.503,P 0.05),calcification was positively correlated with lymph node metastasis(OR = 1.761,95%CI 1.124 ~2.760,P 0.05).Malignant calcification was positively correlated with ER positive expression(OR =1.710,95%CI 1.078-2.712,P 0.05),and PR positive expression(OR =1.597,95%CI 1.023-2.494,P 0.05).Conclusion Mammography micro-calcification patients were more likely to be in late clinical stage and axillary lymph node metastasis,and ER and PR positive expression,whether as independent prognostic factors remains to be further studied.
出处 《疑难病杂志》 CAS 2013年第11期862-865,共4页 Chinese Journal of Difficult and Complicated Cases
关键词 微钙化 乳腺癌 诊断 预后 Micro-calcifications Breast cancer Diagnosis Prognsis
  • 相关文献

参考文献18

  • 1Luedders DW,Tenggk KH, Hornemann NA,et al. Current diagnostic mo- dalities and clinical pitfalls in malignant secondary breast tumours [ J ]. Arch Gynecol Obstet ,2011,284 ( 10 ) :687 4594.
  • 2Leborgne R. Diagnosis of tumors of the breast by simple roentgemJgraphy : calcifications in carcinoma [ J ]. Am J Roentgenol Radium Ther, 1951, 65(1):1-11.
  • 3Hammond ME,Hayes DF, Dowsett TM, et al. American Society of Clini- cal Oncology/College of American Pathologists guideline recommenda- tions for immunohistochemical testing of estrogen and progesterone recep- tors in breast cancer[ J ]. Journal of Clinical Oncology, 2010, 28 ( 16 ) : 2784-2795.
  • 4<乳腺癌HER2检测指南>编写组,霍临明.乳腺癌HER2检测指南[J].中华病理学杂志,2006,35(10):631-633. 被引量:163
  • 5Cox RF, Santana AH, Ramdass S, et al. Microcalcifications in breast cancer: novel insights into the molecular mechanism and functional con- sequence of mammary mineralization[ J ]. Br J Cancer, 2012,106 ( 3 ) : 525 -237.
  • 6Cancela M L, Conceio N, Laiz6 V. Gla-rich protein, a new player in tis- sue calcification [ J ]. Adv Nutr,2012,3 ( 2 ) : 174-181.
  • 7Lafontan DB, Daures JP, Salicru B, et al. Isolated clustered microcaleifi- cations diagnostic value of mammography : series of 400 cases with surgi- cal verification [ J ]. Radiology, 1994, 190 ( 2 ) :479 483.
  • 8赵俊京,王红光,李智岗,梁国庆,李顺宗.乳腺CR技术规范化探讨[J].中国医学影像技术,2004,20(3):427-429. 被引量:36
  • 9Jiang L. Mammographic features are associated with clinico pathological characteristics in invasive breast cancer [ J ]. Anticancer Rcs, 2011,31 (6) :2327-2334.
  • 10Karamouzis MV, Karatza EL, Ravagiota P,et al. Non-palpable breast car- cinomas: correlation of mammographically detected malignant-appearing microcalcifications and molecular prognostic factors [ J ]. Int J Cancer, 2002,102( 1 ) :86-90.

二级参考文献34

  • 1林玉斌,吴冬梅,孙妮娜.簇状钙化在钼靶X线诊断乳腺癌中的临床意义[J].中国妇幼保健,2006,21(15):2155-2157. 被引量:16
  • 2耿进朝,周玉荣,刘晋红,翁艳,李明山,刘晶哲.乳腺癌的ER、PR、C-erbB-2和P53表达与钼靶X线表现相关性研究[J].中华放射医学与防护杂志,2006,26(5):486-489. 被引量:32
  • 3鲍润贤主编.中华医学影像学.乳腺卷.第1版.北京:人民卫生出版社,2002.116-123.
  • 4胡永升主编.现代乳腺影像诊断学.第1版.北京:科学出版社,2000.344.
  • 5[2]Smathers,RL,Bush E,Drace J,et al.Mammographic microcalcifications:detection with Xerography,screen-film,and digitized film display[J].Radiology,1986,159(3):673-677.
  • 6[5]American College of Radiology(ACR). Mammography qanlity control manual[M]. Reston:American College of Radiology, 1999.9-78.
  • 7Watters AD,Going JJ,Cooke GT,et al.Chromosome 17 aneusomy is associated with poor prognostic factors in invesive breast carcinoma.Breast Cancer Res Treat,2003,77:109-114.
  • 8Bilous M,Morey A,Armes J,et al.Chromogenic in situ hybridisation testing for HER2 gene amplification in breast cancer produces highly reproducible results concordant with fluorescence in situ hybridisation and immunohistochemistry.Pathology,2006,38:120-124.
  • 9Goldhirsch A,Glick JH,Gelber RD,et al.Meeting highlights:international expert consensus on the primary therapy of early breast cancer 2005.Annals Oncol,2005,16:1569-1583.
  • 10The Center For Devices and Radiological Health (CDRH) of the Food and Drug Administration.A document of evaluation about the PathVysionTM HER-2 DNA Probe Kit of Vysis,INC.for detecting amplification of the HER-2/neu gene via fluorescence in situ hybridization (FISH) in formalin-fixed,paraffin-embedded human breast cancer tissue specimens.[2001-12-31].http://www.fda.gov/cdrh/pmapage.html.

共引文献235

同被引文献112

引证文献11

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部